Bio-Techne Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
All right. We'll get started. Hello, everyone. My name is Jay Jin, and I'm part of the health care technology and distribution team here at Credit Suisse. Thanks, everyone, for joining us today.
Next up, we have Jim Hippel, Chief Financial Officer from Bio-Techne for a presentation. By way of background, Bio-Techne engages in development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets.
I will now hand it over to Jim for the presentation. But if anyone from the audience wants to ask any questions, please e-mail them to me at [email protected]. With that, Jim, over to you.
Great, Jay. Thank you very much. It's great to be here. Welcome, everyone. When I give an overview of our company, it's going to be geared probably a little more towards those of you who may not be as aware of our company and what
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |